EUVIMEDEUVIMED entdecken
Open Access

Stromal Expression of Fibroblast Activation Protein Alpha (FAP) Predicts Platinum Resistance and Shorter Recurrence in patients with Epithelial Ovarian Cancer

Paulette Mhawech-Fauceglia, Li Yan, Maryam Sharifian, Xing Ren, Song Liu, Grace Kim, Simon A Gayther, Tanja Pejovic, Kate Lawrenson

Cancer Microenvironment · 2015-04 · 8 (1) · 23-31

DOI: 10.1007/s12307-014-0153-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Microenvironment, online erschienen am 21.10.2014. Verfasst von Paulette Mhawech-Fauceglia und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Southern California/Keck School of Medicine, Los Angeles, CA, USA, pmhawech1@yahoo.com. Die Arbeit wurde bisher 90-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The microenvironment plays an important role in tumorigenesis. Fibroblast activation protein alpha (FAP) is overexpressed by fibroblasts present in the microenvironment of many tumors. High FAP expression is a negative prognostic factor in several malignancies, but this has not been investigated in epithelial ovarian cancer (EOC). The aim of this study is to define the value of FAP in EOC. Immunohistochemical staining using an anti-FAP antibody was performed on 338 EOC tissues. mRNA levels in cancer cell lines and FAP silencing using siRNA was also done. FAP immunoexpression by tumor stroma was a significant predictive factor for platinum resistance (p = 0.0154). In survival analysis of days to recurrence, FAP stoma (+) was associated with shorter recurrence than those with FAP (-) stroma (p = 0.0247). In 21.8 % of tumors, FAP protein was expressed by the tumor epithelium, and FAP mRNA was more highly expressed in tumors (n = 489) than in normal tissues (n = 8) (p = 3.88 × 10(-4)). In vitro, addition of FAP to EOC cells induced a 10-12 % increase in cell viability both in the presence and absence of cisplatin. Conversely, siRNA silencing of FAP resulted in ~10 % reduction in EOC cell proliferation. We have shown that FAP expression in EOC is associated with poorer clinical outcomes. FAP may have novel cell-autonomous effects suggesting that targeting FAP could have pleiotropic anti-tumor effects, and anti-FAP therapy could be a highly effective novel treatment for EOC, especially in cisplatinum-resistant cases.

Autor:innen und Institutionen

  • Department of Pathology, University of Southern California/Keck School of Medicine, Los Angeles, CA, USA, pmhawech1@yahoo.com.

Zitieren

APA

Mhawech-Fauceglia, P., Yan, L., Sharifian, M., Ren, X., Liu, S., Kim, G., Gayther, S. A., Pejovic, T., & Lawrenson, K. (2015). Stromal Expression of Fibroblast Activation Protein Alpha (FAP) Predicts Platinum Resistance and Shorter Recurrence in patients with Epithelial Ovarian Cancer. Cancer Microenvironment, 8(1), 23-31. https://doi.org/10.1007/s12307-014-0153-7

Vancouver

Mhawech-Fauceglia P, Yan L, Sharifian M, Ren X, Liu S, Kim G, et al. Stromal Expression of Fibroblast Activation Protein Alpha (FAP) Predicts Platinum Resistance and Shorter Recurrence in patients with Epithelial Ovarian Cancer. Cancer Microenvironment. 2015;8(1):23-31. doi:10.1007/s12307-014-0153-7

BibTeX
@article{MhawechFauceglia2015,
  author = {Mhawech-Fauceglia, Paulette and Yan, Li and Sharifian, Maryam and Ren, Xing and Liu, Song and Kim, Grace and Gayther, Simon A and Pejovic, Tanja and Lawrenson, Kate},
  title = {Stromal Expression of Fibroblast Activation Protein Alpha (FAP) Predicts Platinum Resistance and Shorter Recurrence in patients with Epithelial Ovarian Cancer},
  journal = {Cancer Microenvironment},
  year = {2015},
  volume = {8},
  number = {1},
  pages = {23--31},
  doi = {10.1007/s12307-014-0153-7}
}
Kostenlos starten →